Joe Slavinsky

Joe Slavinsky is a highly accomplished individual with a strong educational background. He studied Biology at Vanderbilt University for his BA, followed by an MPH in Epidemiology at Tulane University School of Public Health and Tropical Medicine. Additionally, he obtained a PhD in Epidemiology from Tulane University.

Throughout his career, Joe has held various senior roles in prestigious organizations. He was the Co-Founder and Chief Business Officer at Marley Medical, the Senior Vice President of Business Development at Propeller Health, and engaged in Corporate Development and Commercial Strategy at Gilead Sciences. Prior to that, he worked in Strategic Marketing for HIV & Oncology at Monogram Biosciences and consulted for Presidio Pharmaceuticals/Achaogen.

Joe's career also includes significant experience in the finance sector. He served as a Vice President and Senior Equity Research Analyst focusing on Biopharmaceuticals at Thomas Weisel Partners. He also worked as a Portfolio Finance Analyst at Citadel Investment Group.

Overall, Joe Slavinsky has a diverse professional background combining expertise in epidemiology, business development, corporate strategy, marketing, and finance, making him a valuable asset in various industries.